2024-09-24 - Analysis Report
## Regeneron Pharmaceuticals Inc. (REGN) Stock Analysis

**Company Overview:** Regeneron Pharmaceuticals Inc. is a biotechnology company focused on developing and commercializing life-changing medicines for serious diseases.

**Performance Analysis:**

* **Relative Performance:** REGN has underperformed the S&P 500 (VOO) by -25.38%. The current relative performance is at the 47.39% percentile of historical performance, implying that the stock has underperformed for a significant portion of the past.
* **Price Momentum:** The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, indicating potential downward momentum. 
* **Technical Indicators:** The RSI of 32.85 suggests the stock is in oversold territory, while the PPO of -0.66 indicates a potential bearish sentiment. The recent relative divergence of -18.7 signifies a short-term downtrend.
* **Expected Return:** The expected return of 20.88% suggests potential upside potential, although this is based on a 5-year projection.
* **Recent Earnings:** The most recent earnings announcement (2024-08-01) reported an EPS of 13.25 and revenue of $3.55B. While the earnings beat analysts' expectations, the revenue fell short. Historical earnings trends suggest consistent growth in both EPS and revenue.

**Overall Analysis:**

Regeneron Pharmaceuticals Inc. has underperformed the S&P 500 in recent months, with indicators suggesting potential downward momentum.  The stock currently sits in oversold territory, but the expected return suggests potential upside in the long term. Recent earnings demonstrate continued growth, though the revenue missed analysts' expectations. 

**Investment Recommendation:**

Based on the current analysis, REGN might be considered a potential buy for long-term investors with a high-risk tolerance. The stock is currently trading at a discount, and the long-term growth prospects of the company remain strong. However, the recent underperformance and the current bearish technical indicators suggest potential short-term volatility. It is recommended to monitor the stock closely and consider entering the market when it shows signs of a potential rebound. 

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Investing involves inherent risks, and it is essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
